H. Neumayer

发表

Calcium Channel Blockade and Preservation of Renal Graft Function in Cyclosporine-Treated Recipients: A Prospective Randomized Placebo-Controlled 2-Year Study

K. Budde, H. Neumayer, Y. Vanrenterghem, 2004, Transplantation.

Lipoprotein patterns in renal transplant patients: a comparison between FK 506 and cyclosporine A patients.

J. Squifflet, J. Hooff, J. Morales, 1998, Transplantation proceedings.

CONVERSION FROM CYCLOSPORINE TO EVEROLIMUS LEADS TO BETTER RENAL FUNCTION AND TO PROFOUND CHANGES IN EVEROLIMUS AND MYCOPHENOLATE METABOLISM

K. Budde, W. Arns, P. Glander, 2006 .

Effects of transgenic endothelin‐2 overexpression on diabetic cardiomyopathy in rats

M. Paul, S. Kron, B. Rylski, 2010, European journal of clinical investigation.

Interleukin-6 expression after renal transplantation.

K. Budde, A. Katalinic, J. Waiser, 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Interleukin-8 expression in patients after renal transplantation.

K. Budde, A. Katalinic, M. Ceska, 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

The influence of age on outcome after renal transplantation.

K. Budde, T. Böhler, J. Waiser, 1997, Geriatric nephrology and urology.

Dialysis Transplantation Substitution of conventional cyclosporin with a new microemulsion formulation in renal transplant patients : results after 1 year

F. Luft, K. Budde, R. Kohnen, 2005 .

Novel renal replacement strategies for the elimination of serum free light chains in patients with kappa light chain nephropathy

S. Morgera, O. Sezer, H. Neumayer, 2009, European journal of medical research.

Prognostic value of the Banff classification

K. Budde, T. Böhler, I. Hauser, 2000, Transplant international : official journal of the European Society for Organ Transplantation.

Hirudin versus heparin for anticoagulation in continuous renal replacement therapy

C. Ronco, M. Welte, O. V. Hein, 2001, Intensive Care Medicine.

Treatment of acute c-ANCA-positive vasculitis with mycophenolate mofetil.

K. Budde, J. Waiser, H. Neumayer, 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Multicenter prospective observational study on safety and efficacy of regional citrate anticoagulation in CVVHD in the presence of liver failure: the Liver Citrate Anticoagulation Threshold Study (L-CAT)

T. Slowinski, S. Morgera, R. Stocker, 2011, Critical Care.

PLACEBO-CONTROLLED STUDY OF MYCOPHENOLATE MOFETIL COMBINED WITH CYCLOSPORINE AND CORTICOSTEROIDS FOR PREVENTION OF ACUTE REJECTION

P Fauchald, Francesc Moreso, Rudolf Pichlmayr, 1995 .

Citrate anticoagulation protocol for slow extended hemodialysis with the Genius dialysis system in acute renal failure.

T. Slowinski, S. Morgera, H. Peters, 2008, The International journal of artificial organs.

Mycophenolate mofetil pharmacokinetics in renal transplant recipients on peritoneal dialysis

K. Budde, S. Morgera, H. Neumayer, 1998, Transplant international : official journal of the European Society for Organ Transplantation.

Acute cellular rejection with isolated v‐lesions is not associated with more favorable outcomes than vascular rejection with more tubulointerstitial inflammations

K. Budde, D. Schmidt, B. Rudolph, 2014, Clinical transplantation.

Emerging indications for MARS dialysis.

S. Morgera, H. Lochs, G. Schachschal, 2002, Liver.

Reactivation of tuberculosis after conversion from azathioprine to mycophenolate mofetil 16 years after renal transplantation.

K. Budde, J. Waiser, H. Neumayer, 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Renal replacement therapy with high cutoff hemofilters: impact of convection and diffusive on cytokine clearances and protein status

R. Bellomo, S. Morgera, C. Melzer, 2004, Critical Care.

De novo hemolytic uremic syndrome postrenal transplant after cytomegalovirus infection.

K. Budde, B. Rudolph, M. Ortner, 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Plasma pharmacokinetics of daptomycin in critically ill patients with renal failure and undergoing CVVHD.

T. Slowinski, C. Spies, A. Uhrig, 2011, International journal of clinical pharmacology and therapeutics.

Super High Flux Hemodialysis at High Dialysate Flows: An Ex Vivo Assessment

R. Bellomo, S. Morgera, H. Neumayer, 2004, The International journal of artificial organs.

Pharmacodynamics of FTY720, the first member of a new class of immune-modulating therapeutics in transplantation medicine.

K. Budde, T. Böhler, J. Waiser, 2003, International journal of clinical pharmacology and therapeutics.

FTY720 alters the composition of T-lymphocyte subpopulations in the peripheral blood compartment of renal transplant patients.

K. Budde, J. Waiser, H. Neumayer, 2002, Transplantation Proceedings.

Conversion from Sandimmun to Sandimmun Neoral in patients with stable renal allografts: results after 1 month.

R. Kohnen, L. Färber, J. Vollmar, 1994, Transplantation proceedings.

Substitution of conventional cyclosporin with a new microemulsion formulation in renal transplant patients: results after 1 year.

F. Luft, K. Budde, R. Kohnen, 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Efficacy and safety of intermittent hemodialysis using citrate as anticoagulant: a prospective study.

S. Morgera, D. Kindgen-Milles, H. Peters, 2007, Clinical Nephrology.

ß2-Microglobulin Clearance with Super High Flux Hemodialysis: an Ex Vivo Study

R. Bellomo, S. Morgera, H. Goehl, 2003, The International journal of artificial organs.